Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00267501 · ClinicalTrials.gov registry record
Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
A clinical trial of Food Allergy and Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT00267501 is a study of Food Allergy and Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 5,000 participants, above the 670-participant average among 17 other Food Allergy trials with a reported enrollment target (646% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00267501, a study of Food Allergy and Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to elucidate the mechanisms underlying eosinophil growth, survival, migration, and function and to investigate and further characterize the pathophysiology of, clinical manifestations of, and spectrum of disease severity of eosinophilic inflammation in humans.
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2005-05 |
| Est. Completion | 2050-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00267501
The ClinicalTrials.gov registry entry for NCT00267501 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 670-participant average among 17 other Food Allergy trials with a reported enrollment target (646% higher). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Food Allergy appearing as the primary indexed condition, and to 0 interventions.
NCT00267501 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00267501 about?
NCT00267501 is a clinical study titled "Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders". The purpose of this study is to elucidate the mechanisms underlying eosinophil growth, survival, migration, and function and to investigate and further characterize the pathophysiology of, clinical manifestations of, and spectrum of disease severity of eosinophilic inflammation in humans.
What is the current status of trial NCT00267501?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2005-05. Estimated completion is 2050-01.
What conditions does trial NCT00267501 study?
This clinical trial studies the following conditions: Food Allergy, Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease.
Who is sponsoring clinical trial NCT00267501?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00267501 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Food Allergy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Omalizumab in the Skin of Food Allergy Patients
RECRUITING · Phase 4
-
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
RECRUITING · Phase 1
-
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
RECRUITING · Phase 2
-
Natural History and Genetics of Food Allergy and Related Conditions
RECRUITING
-
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
RECRUITING · NA
-
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
RECRUITING · Phase 1
Explore more on PlainTrial
Food Allergy
All registered trials for this condition
Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease
All registered trials for this condition
Ohio
All trials with a study site in Ohio
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.